Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVR NYSE:INFU NASDAQ:PYPD NASDAQ:STSS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$4.90-6.5%$3.94$2.34▼$8.79$188.97MN/A258,484 shs265,560 shsINFUInfuSystem$10.41+4.1%$8.51$4.61▼$11.04$212.64M1.82183,676 shs420,443 shsPYPDPolyPid$3.55+2.9%$3.48$2.30▼$3.93$54.85M1.4852,002 shs48,540 shsSTSSSharps Technology$7.91-3.1%$7.63$3.36▼$1,603.80$216.27M2.283.58 million shs181,478 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-6.49%-15.81%+18.07%+21.59%+489,999,900.00%INFUInfuSystem+4.10%+2.46%+8.78%+66.29%+61.15%PYPDPolyPid+2.90%+4.72%+1.43%-0.84%+2.60%STSSSharps Technology-3.06%-11.02%+7.47%+38.77%+790,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$4.90-6.5%$3.94$2.34▼$8.79$188.97MN/A258,484 shs265,560 shsINFUInfuSystem$10.41+4.1%$8.51$4.61▼$11.04$212.64M1.82183,676 shs420,443 shsPYPDPolyPid$3.55+2.9%$3.48$2.30▼$3.93$54.85M1.4852,002 shs48,540 shsSTSSSharps Technology$7.91-3.1%$7.63$3.36▼$1,603.80$216.27M2.283.58 million shs181,478 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-6.49%-15.81%+18.07%+21.59%+489,999,900.00%INFUInfuSystem+4.10%+2.46%+8.78%+66.29%+61.15%PYPDPolyPid+2.90%+4.72%+1.43%-0.84%+2.60%STSSSharps Technology-3.06%-11.02%+7.47%+38.77%+790,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 3.00Buy$16.50236.73% UpsideINFUInfuSystem 3.75Strong Buy$13.3328.08% UpsidePYPDPolyPid 3.17Buy$12.40249.30% UpsideSTSSSharps Technology 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PYPD, INFU, AVR, and STSS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/22/2025INFUInfuSystemLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$15.008/14/2025PYPDPolyPidCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.00 ➝ $13.008/14/2025PYPDPolyPidRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy8/13/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$13.007/22/2025INFUInfuSystemRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$12.007/21/2025INFUInfuSystemRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy(Data available from 9/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$2.70M65.44N/AN/A$1.74 per share2.82INFUInfuSystem$139.89M1.52$0.81 per share12.79$2.47 per share4.21PYPDPolyPidN/AN/AN/AN/A$0.75 per shareN/ASTSSSharps TechnologyN/AN/AN/AN/A$110.01 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies Global-$76.29MN/A0.00N/AN/AN/AN/AN/A11/10/2025 (Estimated)INFUInfuSystem$870K$0.23173.5333.58N/A1.12%2.78%1.41%N/APYPDPolyPid-$29.02M-$3.83N/A∞N/AN/A-453.95%-138.92%11/12/2025 (Estimated)STSSSharps Technology-$9.30M-$1,212.34N/A∞N/AN/A-8.72%-5.30%N/ALatest PYPD, INFU, AVR, and STSS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025PYPDPolyPid-$0.53-$0.78-$0.25-$0.78N/AN/A8/13/2025Q2 2025STSSSharps Technology-$0.94$3.58+$4.52$3.58$0.25 million$0.22 million8/11/2025Q2 2025 TUAVRAnteris Technologies Global-$0.5333-$0.58-$0.0467-$0.58$0.58 million$0.62 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/APYPDPolyPidN/AN/AN/AN/AN/ASTSSSharps TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/A2.412.38INFUInfuSystem0.501.981.59PYPDPolyPidN/A2.282.28STSSSharps TechnologyN/A4.353.67Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/AINFUInfuSystem71.13%PYPDPolyPid26.47%STSSSharps Technology17.17%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies Global4.00%INFUInfuSystem11.40%PYPDPolyPid24.70%STSSSharps Technology0.15%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13836.06 million34.62 millionN/AINFUInfuSystem41020.43 million19.10 millionOptionablePYPDPolyPid8015.90 million11.97 millionNo DataSTSSSharps Technology326.50 million26.46 millionNot OptionablePYPD, INFU, AVR, and STSS HeadlinesRecent News About These CompaniesSharps Technology Raises $410M for Solana StrategySeptember 17, 2025 | theglobeandmail.comSharps Technology, BONK announce staking collaborationSeptember 16, 2025 | msn.comSharps Technology files $1B mixed securities shelfSeptember 15, 2025 | msn.comSharps Technology files $1 billion mixed shelf offeringSeptember 15, 2025 | msn.comSharps Technology, Inc. (NASDAQ:STSS) Sees Large Increase in Short InterestSeptember 12, 2025 | americanbankingnews.comSolana Gets Institutional Boost from Sharps and Pudgy PenguinsSeptember 11, 2025 | coinlaw.ioCSharps Technology, Pudgy Penguins announce strategic partnershipSeptember 10, 2025 | msn.comSharps Technology and Pudgy Penguins Announce Strategic PartnershipSeptember 10, 2025 | prnewswire.comNew to The Street Signs Media Partnership with Sharps Technology (NASDAQ: STSS) as Company Announces Over $400M Solana (SOL) Treasury AcquisitionSeptember 4, 2025 | kansascity.comKSharps Technology acquires over 2 million SOLSeptember 2, 2025 | msn.comSharps Technology Enters Equity Sales AgreementSeptember 2, 2025 | tipranks.comSharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public BlockchainSeptember 2, 2025 | tmcnet.comSharps Technology Inc: Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public BlockchainSeptember 2, 2025 | finanznachrichten.deSharps Technology launches Solana treasury with $400M raise that could reach $1BAugust 29, 2025 | msn.comSharps Technology secures $400M, launches crypto treasuryAugust 29, 2025 | mobihealthnews.comMTimothy James Ruemler Sells 20,000 Shares of Sharps Technology (NASDAQ:STSS) StockAugust 29, 2025 | insidertrades.comSharps Technology, Inc. Closes Over $400 Million Private Placement, Launching Solana Digital Asset Treasury StrategyAugust 28, 2025 | prnewswire.comHere's why Sharps Technology stock jumped 56% on WednesdayAugust 27, 2025 | invezz.comISharps Technology, Inc. Stock (STSS) Opinions on $400M Solana Treasury AnnouncementAugust 27, 2025 | quiverquant.comQBrenda Baird Simpson Buys 20,000 Shares of Sharps Technology (NASDAQ:STSS) StockAugust 27, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesNIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20252 Data Center REITs That Look Good in Any PortfolioBy Sam Quirke | September 8, 2025Take Profits Now: 3 Overbought Stocks Primed for a PullbackBy Dan Schmidt | August 25, 2025What NVIDIA’s Big Bet on Rival Quantinuum Means for D-Wave StockBy Nathan Reiff | September 8, 2025From Debt to Liftoff: EchoStar's $23 Billion CatalystBy Jeffrey Neal Johnson | August 27, 2025PYPD, INFU, AVR, and STSS Company DescriptionsAnteris Technologies Global NASDAQ:AVR$4.90 -0.34 (-6.49%) As of 09/22/2025 04:00 PM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.InfuSystem NYSE:INFU$10.41 +0.41 (+4.10%) Closing price 09/22/2025 04:00 PM EasternExtended Trading$10.21 -0.20 (-1.96%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.PolyPid NASDAQ:PYPD$3.55 +0.10 (+2.90%) Closing price 09/22/2025 04:00 PM EasternExtended Trading$3.54 -0.01 (-0.28%) As of 09/22/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.Sharps Technology NASDAQ:STSS$7.91 -0.25 (-3.06%) Closing price 09/22/2025 04:00 PM EasternExtended Trading$7.90 -0.02 (-0.19%) As of 05:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 High-Yields at 52-Week Lows: Buy, Sell, or Hold Advance Auto Parts is A Great Risk/Reward Play If EPS Delivers 3 Small Caps That Insiders Are Buying Banks Boost Gold Forecasts: One Sees +30% Bull-Case Potential These 3 Stocks Boosting Buybacks Have Rallying Potential GameStop Partying Like It’s 2021: What’s Behind Its 2025 Rebound? Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy Why Robinhood Stock Is Soaring—and What Comes Next Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
